Abstract:Background: Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is considered to result from the interaction of environmental factors, including intestinal microbiota, with host immune mechanisms in genetically susceptible individuals. Association studies in human and mice indicate that no single organisms are causal for IBD, but instead reflect a broad dysbiosis, suggesting that distinct organisms sharing similar traits may be operative. Owing to the complexity and low inter-individual overlap of the intestinal microbiota, no biologically and ecologically integrated microbial signature of this dysbiosis has been identified in IBD. Results: We performed a study of endoscopic lavage samples from different anatomical sites in 64 subjects (32 normal (NM), 16 CD and 16 UC patients in remission). The V4 region of the 16S ribosomal RNA gene of 190 total mucosal lavage samples was sequenced on an Illumina HiSeq 2000. The microbial composition of lavage specimens was more similar to mucosal biopsies versus fecal compartment (phylum-level Pearson similarity analysis with published datasets), suggesting that mucosal lavage sampling is a good reflection of mucosal-associated microbiota. Phylogenetic diversity was reduced in IBD patients compared to NM subjects. While expected from prior studies of active disease, this is the first demonstration that such differences persist in clinically quiescent phases of disease. A subset of IBD-enriched microbial communities was identified by PCoA of the unweighted UniFrac distance matrix. Network-based analysis of microbial co-occurrence patterns identified 8 functional microbial communities (FMCs). Only one FMC was related to any of the previously reported fecal enterotypes. Bioinformatic validation with two independent mucosal (biopsy) datasets showed that these FMCs are a significantly preserved characteristic of the mucosal surface ecology. Two FMCs were positively and negatively associated with IBD phenotype, and with ATG16L1 and NOD2 risk alleles. Conclusions: We have introduced mucosal lavage as a new sampling method to study host-microbial interaction, and module analysis to identify integrated mucosal ecology parameters for microbial community structure. Our results demonstrate the feasibility of detecting subtle variation between NM and IBD microbiota using relatively short Illumina reads. The identification of FMCs indicated that the intestinal microbiota can be defined as a set of reproducible microbial communities, and that a subset of these are selectively augmented or depleted in IBD patient samples, and with related disease-associated genotypes. Such disease-associated communities provide a new tool to define disease states as microbial ecologic units, and potentially novel integrated units to monitor deleterious microbial states and for therapeutic targeting.

Detection and Identification of Inflammatory Bowel Disease Electronic Nose

A Novel Tool For Noninvasive Diagnosis And Tracking Of Patients With Inflammatory Bowel Disease

Detecting inflammatory bowel disease through an electronic nose

Breath Analysis Using Enose and Ion Mobility Technology to Diagnose Inflammatory Bowel Disease—A Pilot Study

Development and Application of a New Electronic Nose Instrument for the Detection of Colorectal Cancer.

Smart Electronic Nose for the Detection of Exhaled Breath to Diagnose Small Intestinal Bacterial Overgrowth

Non-Invasive Exhaled Volatile Organic Biomarker Analysis to Detect Inflammatory Bowel Disease (Ibd)

T1267 the Gut in Health and Disease: Scenting the Difference by ‘electronic Nose’

PTH-018 Towards Novel Non Invasive Methods to Diagnose Colorectal Cancer Using an Electronic Noses (E-Nose) and Field Asymmetric Ion Mobility Spectrometry (Faims)

PTH-187 A Novel Non-Invasive Approach to Diagnose Bile Acid Diarrhoea (Bad) using an Electronic Nose (E-Nose) and Field Asymmetric Ion Mobility Spectroscopy (Faims)

PP-006 the Gut in Health and Disease: Scenting the Difference by “electronic Nose”

A NOVEL NON-INVASIVE APPROACH TO DIAGNOSE BILE ACID DIARRHOEA (BAD) USING AN ELECTRONIC NOSE (E-NOSE) AND FIELD ASYMMETRIC ION MOBILITY SPECTROSCOPY (FAIMS)

The Faecal Scent of Inflammatory Bowel Disease: Detection and Monitoring Based on Volatile Organic Compound Analysis.

Noninvasive, microbiome-based diagnosis of inflammatory bowel disease

The use of a gas chromatograph coupled to a metal oxide sensor for rapid assessment of stool samples from irritable bowel syndrome and inflammatory bowel disease patients

Gas Chromatography-Sensor System Aids Diagnosis of Inflammatory Bowel Disease, and Separates Crohn's from Ulcerative Colitis, in Children

Application of a Novel Tool for Diagnosing Bile Acid Diarrhoea

IDDF2022-ABS-0124 Breath Volatile Organic Compounds As Non-Invasive Biomarkers for the Detection and Monitoring of Inflammatory Bowel Disease

Prediction of Inflammatory Bowel Disease Course Based on Fecal Scent

Su1927 Identification of Inflammatory Bowel Disease (IBD) Using Field Asymmetric Ion Mobility Spectrometry (FAIMS)

Su1930 Nuclear Nano-Morphology Markers from Rectal Tissue for the Surveillance of Colorectal Cancer in Patients with Ulcerative Colitis